ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,756,000 | -44.3% | 543,063 | -38.7% | 0.46% | -42.9% |
Q3 2016 | $12,137,000 | -20.0% | 886,561 | -56.8% | 0.80% | -26.1% |
Q2 2016 | $15,168,000 | +35.5% | 2,052,525 | +17.2% | 1.08% | +30.6% |
Q1 2016 | $11,194,000 | +12.5% | 1,751,813 | +10.0% | 0.83% | +16.8% |
Q4 2015 | $9,953,000 | +26.4% | 1,592,527 | +18.1% | 0.71% | +11.5% |
Q3 2015 | $7,873,000 | -23.7% | 1,348,195 | +8.0% | 0.64% | -31.3% |
Q2 2015 | $10,320,000 | +21.8% | 1,247,917 | +21.4% | 0.93% | +5.1% |
Q1 2015 | $8,473,000 | +7.0% | 1,028,263 | -10.8% | 0.88% | -13.5% |
Q4 2014 | $7,917,000 | +122.4% | 1,152,466 | +74.8% | 1.02% | +9.6% |
Q3 2014 | $3,560,000 | -11.0% | 659,232 | +5.0% | 0.93% | -14.6% |
Q2 2014 | $4,000,000 | +70.6% | 627,968 | +115.9% | 1.09% | +7.7% |
Q1 2014 | $2,345,000 | +79.1% | 290,886 | +51.5% | 1.01% | +7.2% |
Q4 2013 | $1,309,000 | – | 191,965 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |